• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

香港儿童格雷夫斯病发病率上升:一项随访研究。

Increasing incidence of childhood Graves' disease in Hong Kong: a follow-up study.

作者信息

Wong G W, Cheng P S

机构信息

Department of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, N.T., Hong Kong.

出版信息

Clin Endocrinol (Oxf). 2001 Apr;54(4):547-50. doi: 10.1046/j.1365-2265.2001.01252.x.

DOI:10.1046/j.1365-2265.2001.01252.x
PMID:11318792
Abstract

OBJECTIVE

Childhood Graves' disease has been reported to be rare but preliminary epidemiological data on its incidence appeared to be high in Hong Kong Chinese children. The aim of this study is to determine the incidence of childhood Graves' disease in Hong Kong and to analyse whether there is an increasing trend of the incidence.

PATIENTS AND DESIGN

We established a registry of childhood Graves' disease at our centre to collect cases from four districts in Hong Kong. The diagnosis of Graves' disease was based on clinical features, diffused enlargement of thyroid gland, raised free thyroxine or triiodothyronine levels, suppressed TSH levels, and the presence of thyroid receptor antibodies. Confirmed cases of Graves' disease who resided in any of the four districts were used to calculate the incidence for the study period between 1989 and 1998.

RESULTS

One hundred and eighteen Chinese children under 15 years of age had a confirmed diagnosis of Graves' disease during the study period from January 1989 to December 1998. There were 11 boys and 107 girls giving a male to female ratio of 1 : 9.7. The overall incidence rates were 3.2/100 000/year and 6.5/100 000/year for the two periods 1989-93 and 1994-98, respectively. The incidence rates for girls have increased significantly (P < 0.001) from 3.8/100 000/year in 1989 to 14.1/100 000/year in 1998. The current incidence of childhood Graves' disease in our population is about eight times that reported in Danish children.

CONCLUSIONS

This study confirms the high incidence of childhood Graves' disease in Hong Kong and documents an increasing trend for girls. Further studies are required to reveal possible genetic or environmental factors responsible for such epidemiology in Hong Kong Chinese children.

摘要

目的

据报道儿童格雷夫斯病较为罕见,但香港中国儿童中关于其发病率的初步流行病学数据似乎较高。本研究的目的是确定香港儿童格雷夫斯病的发病率,并分析发病率是否存在上升趋势。

患者与设计

我们在本中心建立了儿童格雷夫斯病登记处,以收集香港四个地区的病例。格雷夫斯病的诊断基于临床特征、甲状腺弥漫性肿大、游离甲状腺素或三碘甲状腺原氨酸水平升高、促甲状腺激素水平降低以及甲状腺受体抗体的存在。居住在四个地区中任何一个地区的确诊格雷夫斯病病例用于计算1989年至1998年研究期间的发病率。

结果

在1989年1月至1998年12月的研究期间,118名15岁以下的中国儿童被确诊为格雷夫斯病。其中有11名男孩和107名女孩,男女比例为1:9.7。1989 - 1993年和1994 - 1998年这两个时期的总体发病率分别为每年3.2/10万和每年6.5/10万。女孩的发病率从1989年的每年3.8/10万显著增加(P < 0.001)到1998年的每年14.1/10万。我们人群中儿童格雷夫斯病的当前发病率约为丹麦儿童报道发病率的八倍。

结论

本研究证实了香港儿童格雷夫斯病的高发病率,并记录了女孩发病率的上升趋势。需要进一步研究以揭示导致香港中国儿童出现这种流行病学情况的可能遗传或环境因素。

相似文献

1
Increasing incidence of childhood Graves' disease in Hong Kong: a follow-up study.香港儿童格雷夫斯病发病率上升:一项随访研究。
Clin Endocrinol (Oxf). 2001 Apr;54(4):547-50. doi: 10.1046/j.1365-2265.2001.01252.x.
2
High incidence of juvenile Graves' disease in Hong Kong.香港青少年格雷夫斯病的高发病率。
Clin Endocrinol (Oxf). 1995 Dec;43(6):697-700. doi: 10.1111/j.1365-2265.1995.tb00537.x.
3
The HLA-DQ associations with Graves' disease in Chinese children.中国儿童中HLA - DQ与格雷夫斯病的关联。
Clin Endocrinol (Oxf). 1999 Apr;50(4):493-5. doi: 10.1046/j.1365-2265.1999.00661.x.
4
CTLA-4 gene A-G polymorphism and childhood Graves' disease.细胞毒性T淋巴细胞相关抗原4基因A - G多态性与儿童Graves病
Clin Endocrinol (Oxf). 2002 May;56(5):649-53. doi: 10.1046/j.1365-2265.2002.01234.x.
5
Pediatric stroke among Hong Kong Chinese subjects.香港华裔儿童的中风情况。
Pediatrics. 2004 Aug;114(2):e206-12. doi: 10.1542/peds.114.2.e206.
6
Goitre in southern Chinese children in Hong Kong.中国香港地区南方儿童的甲状腺肿
Ann Trop Paediatr. 1995;15(1):27-31. doi: 10.1080/02724936.1995.11747745.
7
Epidemiology of diabetes mellitus in children in Hong Kong: the Hong Kong childhood diabetes register.香港儿童糖尿病流行病学:香港儿童糖尿病登记处
J Pediatr Endocrinol Metab. 2000 Mar;13(3):297-302. doi: 10.1515/jpem.2000.13.3.297.
8
Serum immunoglobulin G4 levels and Graves' disease phenotype.血清免疫球蛋白G4水平与格雷夫斯病表型
Endocrine. 2017 Feb;55(2):478-484. doi: 10.1007/s12020-016-1157-5. Epub 2016 Nov 7.
9
Myasthenia gravis in Hong Kong Chinese. 2. Paediatric disease.香港华人中的重症肌无力。2. 儿科疾病。
Acta Neurol Scand. 1992 Jul;86(1):68-72. doi: 10.1111/j.1600-0404.1992.tb08056.x.
10
Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.采用人促甲状腺激素受体的新型促甲状腺激素结合抑制活性测定法在抗甲状腺药物治疗的格雷夫斯病随访中的临床价值。与促甲状腺激素刺激抗体生物测定法的比较。
Clin Endocrinol (Oxf). 2001 Jan;54(1):89-96. doi: 10.1046/j.1365-2265.2001.01197.x.

引用本文的文献

1
Radioactive Iodine Therapy for Pediatric Graves' Hyperthyroidism.放射性碘治疗儿童格雷夫斯病甲亢
Med Sci Monit. 2025 Aug 26;31:e948910. doi: 10.12659/MSM.948910.
2
Overall, sex-and race/ethnicity-specific prevalence of thyroid dysfunction in US adolescents aged 12-18 years.美国 12-18 岁青少年甲状腺功能障碍的性别和种族/民族特异性流行率。
Front Public Health. 2024 Jun 20;12:1366485. doi: 10.3389/fpubh.2024.1366485. eCollection 2024.
3
Tall stature and gigantism in transition age: clinical and genetic aspects-a literature review and recommendations.
青春期身材高大和巨人症:临床和遗传方面——文献综述及建议。
J Endocrinol Invest. 2024 Apr;47(4):777-793. doi: 10.1007/s40618-023-02223-z. Epub 2023 Oct 27.
4
Different doses of methimazole treatment of children and adolescents with graves' disease: a clinical study based on 161 cases of outpatients.不同剂量甲巯咪唑治疗儿童及青少年 Graves 病:基于 161 例门诊患者的临床研究。
BMC Endocr Disord. 2023 Oct 23;23(1):233. doi: 10.1186/s12902-023-01484-2.
5
Psychometric properties of EQ-5D-5L for use in patients with Graves' disease.格雷夫斯病患者使用 EQ-5D-5L 的心理测量学特性。
Health Qual Life Outcomes. 2023 Aug 15;21(1):90. doi: 10.1186/s12955-023-02177-z.
6
Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves' disease in children.CTLA-4基因rs231775位点多态性与儿童Graves病易感性的Meta分析。
Open Life Sci. 2023 Apr 28;18(1):20220589. doi: 10.1515/biol-2022-0589. eCollection 2023.
7
Remission in pediatric Graves' disease treated with antithyroid drug and the risk factors associated with relapse.抗甲状腺药物治疗儿童Graves病的缓解情况及复发相关危险因素
Ann Pediatr Endocrinol Metab. 2022 Dec;27(4):308-314. doi: 10.6065/apem.2244038.019. Epub 2022 Dec 31.
8
Graves' disease: moving forwards.格雷夫斯病:不断前行。
Arch Dis Child. 2023 Apr;108(4):276-281. doi: 10.1136/archdischild-2022-323905. Epub 2022 Jul 13.
9
[Definitive treatment of Graves' disease in children].[儿童格雷夫斯病的确定性治疗]
Probl Endokrinol (Mosk). 2022 Apr 11;68(2):104-111. doi: 10.14341/probl13086.
10
2022 European Thyroid Association Guideline for the management of pediatric Graves' disease.2022年欧洲甲状腺协会儿童格雷夫斯病管理指南
Eur Thyroid J. 2022 Jan 1;11(1):e210073. doi: 10.1530/ETJ-21-0073.